Adrenomed AG is translating the concept of precision medicine to acute care with a biomarker-guided antibody therapy for sepsis and septic shock. With a mortality rate of 20–30% in developed ...
in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was reviewed to identify published trials, case reports, and case series on the use of ...
known as the Severe Sepsis/Septic Shock Management Bundle (SEP-1). A new study led by the Center for Sepsis Epidemiology and Prevention Studies (SEPSIS) at the Harvard Pilgrim Health Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results